A. Kudlac

Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison

S. Palmer, B. Barber, Zhongyun Zhao, 2016, Advances in Therapy.

Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study

A. Palumbo, R. Vij, D. Cella, 2018, Annals of Hematology.

Indirect Treatment Comparison of Talimogene Laherparepvec Compared with Ipilimumab and Vemurafenib for the Treatment of Patients with Metastatic Melanoma

S. Palmer, B. Barber, Zhongyun Zhao, 2016, Advances in Therapy.

The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study

J. Utikal, P. Ascierto, L. Bastholt, 2018, Melanoma research.

Clinician Concepts of Cure in Adult Relapsed and Refractory Philadelphia-Negative B Cell Precursor Acute Lymphoblastic Leukemia: A Delphi Study

X. Thomas, J. McKendrick, B. Barber, 2019, Advances in Therapy.